Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-30

FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Montelukast Sodium by Rising Pharma Holdings, Inc., enabling a generic version of Montelukast sodium. Montelukast is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)